Physical Therapists in Malverne, NY Accepting Medicare

10 Physical Therapists found. Showing 1 - 10

Mrs. Alissa Mauceri, D.P.T. Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 4 Weber Ave, Malverne, NY 11565 Phone: 516-599-3999

Dr. Marisa Kendric, PT, DPT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 60 Clinton St, Malverne, NY 11565 Phone: 917-821-7897

Elizabeth K Hoistad, P.T. Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 4 Weber Ave, Malverne, NY 11565 Phone: 516-599-3999    Fax: 516-887-8106

Mrs. Amitha Raghubir, PT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 15 Broadway, Malverne, NY 11565 Phone: 908-216-4408

Mrs. Karen Sue Greenfield, PT Physical Therapist Medicare: Medicare Enrolled Practice Location: 4 Weber Ave, Malverne, NY 11565 Phone: 516-410-5181

Mrs. Ellen Gail Naiman Michaels, P.T. Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 4 Weber Ave, Malverne, NY 11565 Phone: 516-599-3999

Dr. Jaianti Parbhunath Singh, PT, DPT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 101 Linden St, Malverne, NY 11565 Phone: 516-284-6800

Mrs. Veronica Christman Nealon, M.S., P.T. Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 39 Ogston Ter, Malverne, NY 11565 Phone: 516-593-3899

Mrs. Leonor F. Molina, M.A., P.T. Physical Therapist - Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 31 William St, Malverne, NY 11565 Phone: 516-887-4059

Katherine Elizabeth Smith Physical Therapist Medicare: Medicare Enrolled Practice Location: 77 Church St, Malverne, NY 11565 Phone: 516-495-4898

News Archive

Experimental drug for ALS shows promising results in clinical trial

An experimental medication slows the progression of the neurodegenerative disease called Amyotrophic lateral sclerosis (ALS), or Lou Gehrig's disease, according to recently released results from a clinical trial run by investigators at the Sean M. Healey & AMG Center for ALS at Massachusetts General Hospital and Amylyx Pharmaceuticals, Inc., the company that manufactures the medication.

Scientists discover previously unrecognized signaling network disrupted in lung cancer

A team of researchers led by Dr. Goutham Narla at Case Western Reserve University School of Medicine in collaboration with scientists at Mount Sinai School of Medicine in New York, have discovered a previously unrecognized signaling network disrupted in lung cancer that can be turned back on by a novel combination of two previously approved FDA drugs.

Baby due as a result of first ever whole ovary transplant

In what is thought to be a world-first, a British woman who was given an ovary transplant is about to give birth to her first baby.

New 'Vienna Model' for assessment of bilingual children with suspected language impairment

Around 45% of children in Austrian day nurseries have a first language other than German. Those who our experiencing difficulty in learning the second language are often diagnosed as having a suspected "impairment of language acquisition".

Halting the development of certain pancreatic, ovarian, colon and lung cancers may be possible with new therapy

By investigating a single molecule that influences cell growth, a research group in the Purdue Cancer Center, including Brian S. Henriksen, has gained new insight into the chain of events that make some cancer cells divide uncontrollably, insight that may eventually lead to a way to break that chain, stopping cancer in its tracks. The molecule, known as Icmt, has a critical role in the development of Ras, an ordinarily beneficial protein that tells a cell to divide. The research group has determined how to inhibit Icmt's influence on Ras, without which the protein cannot develop effectively into an instigator of cell growth.

Read more Medical News

› Verified 1 days ago